Jobs, Jobs and More Jobs Several counties in the Greater Philadelphia region are expecting an increase in jobs. A Northern Ireland company, Almac Group, has announced its plans to establish its U.S. headquarters in Montgomery County, Pennsylvania. Almac performs integrated research, development and manufacturing services for the pharmaceutical and biotech industries. The 240,000 square foot building in Lower Salford will be used to combine Almac's existing operations, including 500 workers who will be retained, from other parts of the region. The move will allow Almac to create at least 262 new jobs within three years. According to a company press release, “Almac worked with the Montgomery County IDC and local officials to secure a $9.03 million funding offer from the Department of Community and Economic Development, including: a $4.5 million grant through the Infrastructure and Facilities Improvement Program to be disbursed over 10 years; a $2 million Pennsylvania Industrial Development Authority loan; a $1.25 million grant through the Infrastructure Development Program; a $400,000 Opportunity Grant; $100,000 in Customized Job Training funds; and $786,000 in Job Creation Tax Credits. Almac worked closely with the Governor's Action Team, which consists of economic development professionals who serve as a single point-of-contact for businesses considering locating or expanding in Pennsylvania.” In Bucks County, Discovery Laboratories, Inc. plans to consolidate its Doylestown and Warrington locations under one facility, which will allow for the creation of 23 new jobs. Discovery received a $650,000 state incentive package in support of the project, which will also result in the retention of 94 existing employees, including 60 positions at the corporate headquarters. The 23 new jobs will average an annual salary of $80,000, are expected to be created within three years and include chemists, scientists, quality control specialists, support people and positions related to scientific research and formulation. The facility includes a newly completed analytical lab called the Surfaxin Replacement Therapy Institute. Discovery's product platform is based on a novel pulmonary surfactant technology intended to establish a completely new, therapeutic approach in the treatment of respiratory disease, with a targeted initial application in premature infants. And in Philadelphia County, Rotem USA Corp recently signed a 20-year lease in Philadelphia. The 290,000 square foot building will be used to manufacture rail cars for SEPTA and other rail lines. Rotem is a part of the Hyundai Motors Group and expects to create 300 jobs in South Philly as a result of the move.